These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 13265401)

  • 21. [Prolonged therapy of chronic rheumatism with a butazolidin-prednisone preparation].
    BARCZYK W; ROTH G
    Med Klin; 1958 Jul; 53(27):1175-6. PubMed ID: 13565312
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of rheumatoid arthritis with phenylbutazone.
    FREELAND D; STOREY G; THOMPSON M
    Lancet; 1953 Jun; 1(6773):1227-9. PubMed ID: 13053734
    [No Abstract]   [Full Text] [Related]  

  • 23. [Phenylbutazone and lymphocytes in rheumatoid arthritis].
    GOSPODINOFF A; MARINO T
    Prog Med (Napoli); 1956 Feb; 12(4):101-3. PubMed ID: 13323077
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of phenylbutazone on the histomorphology of the synovial membrane in rheumatoid arthritis].
    LUCHERINI T; NATALE P
    Reumatismo; 1954; 6(6):361-72. PubMed ID: 13224912
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenylbutazone (butazolidin).
    KUZELL WC; SCHAFFARZICK RW
    Bull Rheum Dis; 1952 Nov; 3(3):23-4. PubMed ID: 12997961
    [No Abstract]   [Full Text] [Related]  

  • 26. PHENYLBUTAZONE IN THE TREATMENT OF RHEUMATIC DISEASES. A SURVEY AND CLINICAL REPORT.
    STRANDBERG B
    Acta Rheumatol Scand Suppl; 1965; ():SUPPL 10:1-50. PubMed ID: 14338288
    [No Abstract]   [Full Text] [Related]  

  • 27. [TOMANOL THERAPY OF INFLAMMATORY AND OTHER FORMS OF RHEUMATISM].
    BEROVIC Z; NIKOLIC J; LOPICIC L
    Srp Arh Celok Lek; 1964 Feb; 92():117-26. PubMed ID: 14340781
    [No Abstract]   [Full Text] [Related]  

  • 28. [CLINICAL TRIAL OF A COMBINATION PREPARATION OF 2 PYRAZOLE DERIVATIVES IN VARIOUS RHEUMATIC DISEASES].
    GAMARSKI J; ZUPELLI W; BAFUTTO MG
    Hospital (Rio J); 1964 Aug; 66():371-80. PubMed ID: 14193815
    [No Abstract]   [Full Text] [Related]  

  • 29. Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis.
    STEPHENS CA; YEOMAN EE; HOLBROOK WP; HILL DF; GOODIN WL
    J Am Med Assoc; 1952 Nov; 150(11):1084-6. PubMed ID: 12990356
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the treatment of rheumatic diseases with Delta-Tomanol].
    Wille T
    Ther Ggw; 1968 Nov; 107(11):1512-4 passim. PubMed ID: 5306056
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the evaluation of the effectiveness of Butadion in rheumatism and infective arthritis with special reference to results of blood examination].
    PODLIPALINA SA
    Zdravookhranenie Kazakhstana; 1962; 22(2)():31-6. PubMed ID: 14487324
    [No Abstract]   [Full Text] [Related]  

  • 32. The therapeutic effect of phenylbutazone in active periods of rheumatoid arthritis; a control study.
    FJELLSTROM KE; GOLDBERG L; LINDGREN G; NILSSON F
    Acta Med Scand Suppl; 1956; 312():425-8. PubMed ID: 13339215
    [No Abstract]   [Full Text] [Related]  

  • 33. [Butazolidine in the treatment of rheumatism; preliminary note].
    LUCHERINI T; CECCHI E
    Minerva Med; 1953 Feb; 44(10):267-71. PubMed ID: 13063245
    [No Abstract]   [Full Text] [Related]  

  • 34. PHENYLBUTAZONE on trial.
    Br Med J; 1953 Oct; 2(4843):982-3. PubMed ID: 13094091
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic results of butazolidin in chronic rheumatism].
    GOLZ G
    Medizinische; 1954 Oct; 44():1480-2. PubMed ID: 13223292
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical evaluation of phenylbutazone.
    PATTERSON RM; BENSON JF; SCHOENBERG PL
    U S Armed Forces Med J; 1953 Jan; 4(1):109-11. PubMed ID: 13005866
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies of butazolidin and butapyrin in patients with rheumatic diseases.
    KIDD EC; BOYCE KC; FREYBERG RH
    Ann Rheum Dis; 1952 Dec; 11(4):297-300. PubMed ID: 13017486
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenylbutazone therapy; relation between the toxic and therapeutic effects and the blood level.
    BRUCK E; FEARNLEY ME; MEANOCK I; PATLEY H
    Lancet; 1954 Jan; 266(6805):225-8. PubMed ID: 13131825
    [No Abstract]   [Full Text] [Related]  

  • 39. The value of phenylbutazone in the treatment of rheumatoid arthritis as determined by clinical response and by the serum protein-polysaccharide ratio (PR).
    PAYNE RW; SHETLAR MR; FARR CH; HELLBAUM AA; ISHMAEL WK
    J Lab Clin Med; 1955 Mar; 45(3):331-9. PubMed ID: 14354319
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of chronic rheumatism with butazolidin.
    KELLY M
    Med J Aust; 1953 May; 1(20):690-4. PubMed ID: 13062907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.